Share
Scientists have developed a powerful, inclusive new tool for genomic research that boosts efforts to develop more precise treatments for many diseases by leveraging a better representation of the genetic diversity of people around the world.
Share
Virginia Tech researchers in the College of Agriculture and Life Sciences and Virginia-Maryland College of Veterinary Medicine are developing a vaccine to combat the disease that has a near 100 percent mortality rate in newborn piglets.
Share
Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift.
Share
We’ve masked, we’ve vaccinated, we’ve boosted — but are we underutilizing technology that could contain the pandemic because we don’t trust it?
Share
Virginia Tech professor Raffaella De Vita has been awarded a National Science Foundation award to study the biomechanics of gender affirming surgery.
Share
Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.
Share
A cancer stem cell research company founded by Fralin Biomedical Research Institute at VTC scientists is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers.
Share
Mental time travel — transporting someone from the present through imagining a personal, positive future event — has been proven to help reduce alcohol, tobacco, and drug use.
Share
If you have a business idea and you want to maximize your chances of turning that idea into a successful reality, it’s important to do your research proactively.
Share
Through collaboration that incorporates the use of computational modeling, data, and virology, a group of Virginia Tech researchers tackles the latest questions surrounding COVID-19.
